Yoshimura Food Holdings K.K. Logo

Yoshimura Food Holdings K.K.

Acquires and revitalizes Japanese food SMEs via a support platform for global expansion.

2884 | T

Overview

Corporate Details

ISIN(s):
JP3958400008
LEI:
Country:
Japan
Address:
千代田区内幸町二丁目2番2号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Yoshimura Food Holdings K.K. is a holding company dedicated to preserving and growing Japan's food culture. Its core business is the merger and acquisition (M&A) of food-related small and medium-sized enterprises (SMEs) that possess high-quality products and unique manufacturing techniques but face business succession or growth challenges. The company operates a unique "SME support platform," providing comprehensive management assistance to its group companies in areas such as sales, marketing, and product development. This model focuses on long-term value creation and synergy, aiming to revitalize acquired businesses and expand the reach of their diverse food products to both domestic and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-15 09:06
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-10-15 09:05
Interim Report
半期報告書-第18期(2025/03/01-2026/02/28)
Japanese 207.9 KB
2025-06-02 07:08
Post-Annual General Meeting Information
臨時報告書
Japanese 21.4 KB
2025-05-30 07:25
Registration Form
確認書
Japanese 8.1 KB
2025-05-30 07:24
Governance Information
内部統制報告書-第17期(2024/03/01-2025/02/28)
Japanese 22.1 KB
2025-05-30 07:23
Annual Report
有価証券報告書-第17期(2024/03/01-2025/02/28)
Japanese 1.2 MB
2025-04-15 08:08
Management Discussion and Analysis
臨時報告書
Japanese 18.9 KB
2025-04-08 09:53
Capital/Financing Update
臨時報告書
Japanese 19.5 KB
2025-02-28 08:07
Capital/Financing Update
臨時報告書
Japanese 19.3 KB
2025-01-10 06:53
Regulatory News Service
臨時報告書
Japanese 18.5 KB
2024-12-09 08:34
Legal Proceedings Report
臨時報告書
Japanese 18.6 KB
2024-10-15 09:46
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-10-15 09:45
Interim Report
半期報告書-第17期(2024/03/01-2025/02/28)
Japanese 199.7 KB
2024-07-12 08:42
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-07-12 08:41
Quarterly Report
四半期報告書-第17期第1四半期(2024/03/01-2024/05/31)
Japanese 158.7 KB

Automate Your Workflow. Get a real-time feed of all Yoshimura Food Holdings K.K. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Yoshimura Food Holdings K.K.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Yoshimura Food Holdings K.K. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NRGene Technologies Ltd. Logo
AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.
Israel
NRGN
Nuvectis Pharma, Inc. Logo
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea
476060

Talk to a Data Expert

Have a question? We'll get back to you promptly.